Search for stock quotes, financial statistics and more
Stifel analyst Justin Keywood maintained his “Buy” rating and $9.00 target price on WELL Health... Read More
Paradigm Capital analyst Daniel Rosenberg maintained his “Buy” rating and raised his 12-month ta... Read More
Stifel Research analyst Justin Keywood maintained a “Buy” rating on WELL Health Technologies (WE... Read More
Following an update on its Canadian clinics business, Raymond James analyst Michael W. Freeman remai... Read More
Stifel analyst Justin Keywood has maintained a “Buy” rating on WELL Health Technologies (WELL He... Read More
Share
Tweet
pin
Share